Why Some People Respond Better to GLP-1s Than Others
Two people on the same GLP-1 can lose very different amounts of weight. Here’s what actually drives the gap — biology, the drug and dose, side effects, and habits.
Two people on the same GLP-1 can lose very different amounts of weight. Here’s what actually drives the gap — biology, the drug and dose, side effects, and habits.
Chronic low-grade inflammation is mostly a consequence of excess body fat, not a hidden lock that stops you losing weight. Here is what the evidence actually says — and what it doesn’t.
Metabolic flexibility is your body’s ability to switch between burning fat and carbohydrate. Here’s what it is, why it matters, and what actually improves it.
There’s no official GLP-1 protein number, but the evidence points to roughly 1.2–1.6 g/kg/day plus resistance training. Here’s why — and how to actually hit it.
Your weight and your metabolic health are related but not the same thing. Here’s what the scale leaves out — and what’s actually worth tracking.
Sermorelin is increasingly marketed for midlife fatigue, body composition, and anti-aging. Here’s what the evidence actually supports, the fatigue workup we’d do first, and the questions to ask before considering a peptide prescription.
The compounded semaglutide market has narrowed since the FDA removed the drug from its shortage list. Here’s what changed, the questions to ask before starting or continuing, and how we’d think about the decision as clinicians in 2026.
Most adults haven’t had a real blood panel in years — and “normal” on a lab report usually means “not yet diseased,” not thriving. Here are the twelve markers that change earliest and tell you the most.